Davos Life Science has recently published a review article to summarize the current scientific evidences from cellular, animal and clinical studies on the relationship between Vitamin E and Atopic Dermatitis.
Atopic Dermatitis (AD), the most common form of eczema, is a non-contagious, chronic pruritic skin disease that affects approximately 15–20% of children and 3–5% of adults worldwide. It begins early in life, erratically regresses after puberty and some cases will continue into adulthood, affecting both physical health and social life.
A total of 25 studies (5 cellular studies, 4 animal studies and 16 human studies) are included in this systematic review.
The existing studies largely suggest a positive relationship between vitamin E and AD. As such, Vitamin E holds promise as an adjunctive treatment for AD and other skin disorders stemming from oxidative stress and inflammation.
This journal is published in Dermatology (DOI: 10.1159/000510653)
Vitamin E in Atopic Dermatitis: From Preclinical to Clinical Studies